Results 31 to 40 of about 487,201 (201)

Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera.

open access: yesPLoS ONE, 2020
The myeloproliferative neoplasms, polycythemia vera, essential thrombocytosis and primary myelofibrosis are hematopoietic stem cell disorders and share driver mutations that either directly activate the thrombopoietin receptor, MPL, or activate it ...
Jerry L Spivak   +8 more
doaj   +1 more source

Hereditary hemochromatosis and JAK2‐positive polycythemia vera

open access: yesClinical Case Reports, 2021
A 59‐year‐old man was diagnosed with JAK2‐positive polycythemia vera. Subsequently, further laboratory testing revealed elevated ferritin and iron saturation.
Ahmed Radwan, Ibraheem Othman
doaj   +1 more source

The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera

open access: yesHaematologica, 2009
Background The JAK2V617F mutation has been associated with constitutive and enhanced activation of neutrophils, while no information is available concerning other leukocyte subtypes.Design and Methods We evaluated correlations between JAK2V617F mutation ...
Lisa Pieri   +7 more
doaj   +1 more source

Concurrent Polycythemia Vera with Newly Diagnosed Multiple Myeloma: Case Report and Literature Review

open access: yesJournal of Inflammation Research, 2023
Jing Yuan, Xuan Liu, Zhenzhen Wang, Liyuan Li, Fuxu Wang Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of ChinaCorrespondence: Fuxu Wang, Department of Hematology, The Second ...
Yuan J, Liu X, Wang Z, Li L, Wang F
doaj  

Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report

open access: yesJournal of Medical Case Reports, 2018
Background Polycythemia vera is a myeloproliferative disease that sometimes evolves to myelofibrosis, causing splenomegaly and neutropenia. In this case report, we describe a patient with polycythemia vera and unexplained neutropenia who later turned out
Andreas Hanssønn Habberstad   +6 more
doaj   +1 more source

Double Thrombosis- Interesting Case of Polycythemia Vera [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Polycythemia vera is a myeloproliferative disorder which has a varied manifestation, one of it being venous thrombosis and arterial thrombosis which significantly contributes to the mortality and morbidity.
Subashini Subramanian   +1 more
doaj   +1 more source

Polycythemia Vera in a Mixed Breed Dog

open access: yes, 2016
Case Description: A 5.5-year-old male castrated mixed breed dog was evaluated due to an acute onset of neurologic signs, primarily facial spasms, and a marked polycythemia detected by the primary veterinarian.
Wolf, Jake
core   +3 more sources

Manipulating hepcidin in polycythemia vera

open access: yes, 2023
In this issue of Blood, Bennett et al1 provide elegant data supporting the mounting evidence of the critical role of hepcidin, the master regulator of iron metabolism, in the pathophysiology of polycythemia vera (PV).
Girelli, Domenico, Busti, Fabiana
core   +1 more source

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review

open access: yesHaematologica, 2019
Although it is well known that myeloproliferative neoplasms occur in younger patients, few large cohorts of such patients have been reported. Thus, our knowledge about circumstances of diagnosis, outcome and treatment is limited, especially for children ...
Jean-Christophe Ianotto   +5 more
doaj   +1 more source

Polycythemia vera (PV)

open access: yes, 1997
Review on Polycythemia vera (PV), with data on clinics, and the genes ...
Huret, JL, Smadja, N
core   +1 more source

Home - About - Disclaimer - Privacy